223 related articles for article (PubMed ID: 21179007)
1. One-year treatment of morpholino antisense oligomer improves skeletal and cardiac muscle functions in dystrophic mdx mice.
Wu B; Xiao B; Cloer C; Shaban M; Sali A; Lu P; Li J; Nagaraju K; Xiao X; Lu QL
Mol Ther; 2011 Mar; 19(3):576-83. PubMed ID: 21179007
[TBL] [Abstract][Full Text] [Related]
2. Morpholino-induced exon skipping stimulates cell-mediated and humoral responses to dystrophin in mdx mice.
Vila MC; Novak JS; Benny Klimek M; Li N; Morales M; Fritz AG; Edwards K; Boehler JF; Hogarth MW; Kinder TB; Zhang A; Mazala D; Fiorillo AA; Douglas B; Chen YW; van den Anker J; Lu QL; Hathout Y; Hoffman EP; Partridge TA; Nagaraju K
J Pathol; 2019 Jul; 248(3):339-351. PubMed ID: 30883742
[TBL] [Abstract][Full Text] [Related]
3. Long-term rescue of dystrophin expression and improvement in muscle pathology and function in dystrophic mdx mice by peptide-conjugated morpholino.
Wu B; Lu P; Cloer C; Shaban M; Grewal S; Milazi S; Shah SN; Moulton HM; Lu QL
Am J Pathol; 2012 Aug; 181(2):392-400. PubMed ID: 22683468
[TBL] [Abstract][Full Text] [Related]
4. Bubble liposomes and ultrasound exposure improve localized morpholino oligomer delivery into the skeletal muscles of dystrophic mdx mice.
Negishi Y; Ishii Y; Shiono H; Akiyama S; Sekine S; Kojima T; Mayama S; Kikuchi T; Hamano N; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
Mol Pharm; 2014 Mar; 11(3):1053-61. PubMed ID: 24433046
[TBL] [Abstract][Full Text] [Related]
5. Dosing regimen has a significant impact on the efficiency of morpholino oligomer-induced exon skipping in mdx mice.
Malerba A; Thorogood FC; Dickson G; Graham IR
Hum Gene Ther; 2009 Sep; 20(9):955-65. PubMed ID: 19469709
[TBL] [Abstract][Full Text] [Related]
6. Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer.
Wu B; Moulton HM; Iversen PL; Jiang J; Li J; Li J; Spurney CF; Sali A; Guerron AD; Nagaraju K; Doran T; Lu P; Xiao X; Lu QL
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):14814-9. PubMed ID: 18806224
[TBL] [Abstract][Full Text] [Related]
7. Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy.
Blain AM; Greally E; McClorey G; Manzano R; Betts CA; Godfrey C; O'Donovan L; Coursindel T; Gait MJ; Wood MJ; MacGowan GA; Straub VW
PLoS One; 2018; 13(6):e0198897. PubMed ID: 29912990
[TBL] [Abstract][Full Text] [Related]
8. Effects of Chronic, Maximal Phosphorodiamidate Morpholino Oligomer (PMO) Dosing on Muscle Function and Dystrophin Restoration in a Mouse Model of Duchenne Muscular Dystrophy.
Benny Klimek ME; Vila MC; Edwards K; Boehler J; Novak J; Zhang A; Van der Meulen J; Tatum K; Quinn J; Fiorillo A; Burki U; Straub V; Lu QL; Hathout Y; van Den Anker J; Partridge TA; Morales M; Hoffman E; Nagaraju K
J Neuromuscul Dis; 2021; 8(s2):S369-S381. PubMed ID: 34569970
[TBL] [Abstract][Full Text] [Related]
9. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy.
Miyatake S; Mizobe Y; Takizawa H; Hara Y; Yokota T; Takeda S; Aoki Y
Methods Mol Biol; 2018; 1687():123-141. PubMed ID: 29067660
[TBL] [Abstract][Full Text] [Related]
10. Long-term systemic administration of unconjugated morpholino oligomers for therapeutic expression of dystrophin by exon skipping in skeletal muscle: implications for cardiac muscle integrity.
Malerba A; Boldrin L; Dickson G
Nucleic Acid Ther; 2011 Aug; 21(4):293-8. PubMed ID: 21851223
[TBL] [Abstract][Full Text] [Related]
11. A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
Yin H; Moulton HM; Betts C; Seow Y; Boutilier J; Iverson PL; Wood MJ
Hum Mol Genet; 2009 Nov; 18(22):4405-14. PubMed ID: 19692354
[TBL] [Abstract][Full Text] [Related]
12. Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO.
Yin H; Moulton HM; Betts C; Merritt T; Seow Y; Ashraf S; Wang Q; Boutilier J; Wood MJ
Mol Ther; 2010 Oct; 18(10):1822-9. PubMed ID: 20700113
[TBL] [Abstract][Full Text] [Related]
13. Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice.
Wu B; Li Y; Morcos PA; Doran TJ; Lu P; Lu QL
Mol Ther; 2009 May; 17(5):864-71. PubMed ID: 19277018
[TBL] [Abstract][Full Text] [Related]
14. Antisense Oligonucleotide Treatment in a Humanized Mouse Model of Duchenne Muscular Dystrophy and Highly Sensitive Detection of Dystrophin Using Western Blotting.
Maruyama R; Yokota T
Methods Mol Biol; 2021; 2224():203-214. PubMed ID: 33606217
[TBL] [Abstract][Full Text] [Related]
15. Physiological characterization of muscle strength with variable levels of dystrophin restoration in mdx mice following local antisense therapy.
Sharp PS; Bye-a-Jee H; Wells DJ
Mol Ther; 2011 Jan; 19(1):165-71. PubMed ID: 20924363
[TBL] [Abstract][Full Text] [Related]
16. Targeted skipping of human dystrophin exons in transgenic mouse model systemically for antisense drug development.
Wu B; Benrashid E; Lu P; Cloer C; Zillmer A; Shaban M; Lu QL
PLoS One; 2011; 6(5):e19906. PubMed ID: 21611204
[TBL] [Abstract][Full Text] [Related]
17. Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx mice.
Malerba A; Sharp PS; Graham IR; Arechavala-Gomeza V; Foster K; Muntoni F; Wells DJ; Dickson G
Mol Ther; 2011 Feb; 19(2):345-54. PubMed ID: 21102560
[TBL] [Abstract][Full Text] [Related]
18. Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function.
Yin H; Moulton HM; Seow Y; Boyd C; Boutilier J; Iverson P; Wood MJ
Hum Mol Genet; 2008 Dec; 17(24):3909-18. PubMed ID: 18784278
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino.
Wu B; Lu P; Benrashid E; Malik S; Ashar J; Doran TJ; Lu QL
Gene Ther; 2010 Jan; 17(1):132-40. PubMed ID: 19759562
[TBL] [Abstract][Full Text] [Related]
20. Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy.
Echigoya Y; Nakamura A; Nagata T; Urasawa N; Lim KRQ; Trieu N; Panesar D; Kuraoka M; Moulton HM; Saito T; Aoki Y; Iversen P; Sazani P; Kole R; Maruyama R; Partridge T; Takeda S; Yokota T
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4213-4218. PubMed ID: 28373570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
